You may also like

Third Rock Raises $1.1B Fund, Sticks With Its Knitting in a Downturn
MOMA Gets $150M to Make Small Molecules Against ATPases, Laborers of the Cell
Third Rock-Backed Abata Secures $95M for T-reg Cell Therapy Against MS
Betting on Biotech IPOs? What If You Buy the Third Rock and ARCH Portfolios?